「ceoメッセージ」の検索結果
75件：1～5件目を表示
-
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Dry Eye Disease 3 SJP-0132 China Recru
https://www.senju.co.jp/english/rd/trial.html -
お知らせ | 千寿製薬株式会社
March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for BeelineMED”（PDF） January 17, 2025 Senju has Applied for Manufactu
http://www.senju.co.jp/english/news/ -
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other
http://www.senju.co.jp/english/products/apex.html -
Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and o
http://www.senju.co.jp/english/products/ap.html -
OTC Products, etc. | Products | SENJU Pharmaceutical
Inquiries are not accepted in a language other than Japanese in principle. Please kindly understand the situation that the inquiries by telephone must use Japanese only. Translated from the Japanese p
http://www.senju.co.jp/english/products/clg.html